Edwards Lifesciences ROA 2006-2019 | EW

Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Edwards Lifesciences ROA for the three months ending March 31, 2019 was 18.21%.
Edwards Lifesciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-03-31 $0.77B $5.47B 13.66%
2018-12-31 $0.72B $5.32B 12.69%
2018-09-30 $0.71B $5.96B 12.33%
2018-06-30 $0.66B $5.69B 11.59%
2018-03-31 $0.56B $5.83B 10.13%
2017-12-31 $0.58B $5.67B 11.07%
2017-09-30 $0.75B $5.49B 14.96%
2017-06-30 $0.72B $5.14B 15.26%
2017-03-31 $0.66B $4.78B 14.86%
2016-12-31 $0.57B $4.51B 13.61%
2016-09-30 $0.55B $4.34B 13.55%
2016-06-30 $0.53B $4.05B 13.36%
2016-03-31 $0.52B $3.85B 13.38%
2015-12-31 $0.50B $4.06B 13.17%
2015-09-30 $0.46B $3.88B 12.78%
2015-06-30 $0.44B $3.61B 12.60%
2015-03-31 $0.87B $3.49B 25.54%
2014-12-31 $0.81B $3.52B 25.24%
2014-09-30 $0.78B $3.35B 25.82%
2014-06-30 $0.76B $3.33B 27.06%
2014-03-31 $0.31B $2.65B 11.92%
2013-12-31 $0.39B $2.71B 15.75%
2013-09-30 $0.40B $2.53B 17.17%
2013-06-30 $0.40B $2.34B 17.45%
2013-03-31 $0.37B $2.30B 16.84%
2012-12-31 $0.29B $2.22B 13.70%
2012-09-30 $0.27B $2.20B 12.84%
2012-06-30 $0.25B $2.08B 12.33%
2012-03-31 $0.24B $2.00B 11.94%
2011-12-31 $0.24B $1.98B 12.00%
2011-09-30 $0.24B $1.98B 12.44%
2011-06-30 $0.24B $2.00B 12.66%
2011-03-31 $0.24B $1.93B 13.31%
2010-12-31 $0.22B $1.77B 13.00%
2010-09-30 $0.20B $1.73B 12.27%
2010-06-30 $0.23B $1.64B 14.11%
2010-03-31 $0.22B $1.60B 13.87%
2009-12-31 $0.23B $1.62B 15.29%
2009-09-30 $0.22B $1.60B 15.17%
2009-06-30 $0.18B $1.47B 12.85%
2009-03-31 $0.17B $1.36B 12.54%
2008-12-31 $0.13B $1.40B 9.49%
2008-09-30 $0.11B $1.38B 7.94%
2008-06-30 $0.10B $1.35B 7.76%
2008-03-31 $0.10B $1.31B 7.52%
2007-12-31 $0.11B $1.35B 8.77%
2007-09-30 $0.12B $1.30B 9.35%
2007-06-30 $0.12B $1.25B 9.38%
2007-03-31 $0.12B $1.25B 9.45%
2006-12-31 $0.13B $1.25B 10.51%
2006-09-30 $0.15B $1.24B 12.00%
2006-06-30 $0.12B $1.26B 9.60%
2006-03-31 $0.10B $1.24B 7.97%
2005-12-31 $0.08B $1.23B 6.88%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.801B $3.723B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $115.527B 25.27
Intuitive Surgical (ISRG) United States $60.928B 56.14
IDEXX Laboratories (IDXX) United States $24.444B 64.13
Fresenius Medical Care AG KGaA (FMS) Germany $24.394B 16.03
Teleflex (TFX) United States $15.460B 33.50
Olympus (OCPNY) Japan $15.407B 115.28
SONOVA HOLDING (SONVY) Switzerland $14.561B 0.00
Sysmex ADR (SSMXY) Japan $14.417B 38.87
DexCom (DXCM) United States $13.759B 269.84
Hologic (HOLX) United States $12.689B 20.41
STERIS (STE) Ireland $12.575B 30.42
Varian Medical Systems (VAR) United States $12.300B 31.38
ABIOMED (ABMD) United States $11.800B 71.79
Masimo (MASI) United States $8.237B 50.47
Penumbra (PEN) United States $6.000B 254.01
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.599B 21.61
Globus Medical (GMED) United States $4.096B 25.54
Tandem Diabetes Care (TNDM) United States $3.740B 0.00
LivaNova (LIVN) United Kingdom $3.605B 23.50
Wright Medical Group (WMGI) Netherlands $3.365B 667.00
Cantel Medical (CMD) United States $3.364B 34.13
Glaukos (GKOS) United States $2.750B 0.00
Integer Holdings (ITGR) United States $2.675B 19.71
Nihon Kohden (NHNKY) Japan $2.449B 24.64
AVANOS MEDICAL, INC (AVNS) United States $2.029B 32.12
Nevro (NVRO) United States $1.983B 0.00
Inogen (INGN) United States $1.373B 30.40
OPKO Health (OPK) United States $1.317B 0.00
Silk Road Medical (SILK) United States $1.239B 0.00
Veracyte (VCYT) United States $1.167B 0.00
CryoLife (CRY) United States $1.116B 110.70
Accelerate Diagnostics (AXDX) United States $1.055B 0.00
Tactile Systems Technology (TCMD) United States $1.032B 152.33
ORTHOFIX MEDICAL INC (OFIX) United States $0.983B 28.48
Mesa Laboratories (MLAB) United States $0.912B 42.88
Pacific Biosciences Of California (PACB) United States $0.910B 0.00
ViewRay (VRAY) United States $0.907B 0.00
Luminex (LMNX) United States $0.882B 115.35
Natus Medical (BABY) United States $0.880B 20.37
AngioDynamics (ANGO) United States $0.810B 26.55
AxoGen (AXGN) United States $0.767B 0.00
Fluidigm (FLDM) United States $0.759B 0.00
Quotient (QTNT) Switzerland $0.696B 0.00
Intersect ENT (XENT) United States $0.651B 0.00
Corindus Vascular Robotics (CVRS) United States $0.581B 0.00
OrthoPediatrics (KIDS) United States $0.541B 0.00
Si-Bone (SIBN) United States $0.483B 0.00
GenMark Diagnostics (GNMK) United States $0.361B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.354B 18.99
RTI Surgical (RTIX) United States $0.312B 38.36
Accuray (ARAY) United States $0.309B 0.00
TransEnterix (TRXC) United States $0.304B 0.00
Semler Scientific (SMLR) United States $0.289B 57.37
SeaSpine Holdings (SPNE) United States $0.245B 0.00
Neuronetics (STIM) United States $0.235B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
Alphatec Holdings (ATEC) United States $0.208B 0.00
IRadimed (IRMD) United States $0.203B 38.64
CRH Medical (CRHM) Canada $0.201B 69.75
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
Ekso Bionics Holdings (EKSO) United States $0.093B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Vermillion (VRML) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
T2 Biosystems (TTOO) United States $0.069B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.053B 0.00